Global R&D Center
Benta Pharma Industries, based in Lebanon, operates a state-of-the-art Global R&D Center that plays a pivotal role in connecting with world-class scientific talent, cutting-edge technologies, and high-value products. We engage in a variety of cooperative models including independent research and development, collaborative development, licensing, and comprehensive incubation to foster innovation.
Our Global R&D Center is instrumental in managing innovative R&D projects, significantly enhancing our product pipeline with innovative solutions. We focus on expanding our capabilities in research and clinical development, particularly in First-in-class (FIC) and Best-in-class (BIC) new drugs. This strategic approach not only strengthens our research capacity but also speeds up the research, development, and commercial launch of groundbreaking technologies and products.
At Benta Pharma Industries, our commitment to innovation is at the core of our operations, aiming to deliver advanced healthcare solutions that address the needs of tomorrow.
58.85
R&D investment in 2022 (RMB 100 million)
3,600
- R&D
- personnel
1,900+
Personnel with master’s degree or above
24-hour Ongoing R&D Globally
Currently owning diverse pipelines with a suitable gradient for its R&D, which can be used to solve unmet needs, Benta Pharma Industries will actively and decisively expand the layout of R&D pipelines, and speed up the innovation in R&D with the greatest efforts to benefit more patients.

Independent Research and Development

Collaborative Development

License-in

In-depth Incubation







